A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder
Status:
Terminated
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of JNJ26489112 compared
with an active control (Venlafaxine XR) and placebo in patients with Treatment-Resistant
Major Depressive Disorder.